Hottub News

Novo

News mentioning Novo · Wikidata · RSS

Top stories

  1. Novo provides update on the denecimig Biologics License Application (BLA) in the US3 outlets · 2026-10-02 22:30 UTC
  2. Novo will reach new target groups with Wegovy pill2 outlets · 2026-10-02 03:30 UTC
  3. Novo receives criticism for several illegal advertisements for weight loss medication2 outlets · 2026-10-01 16:07 UTC
  4. Novo Nordisk A/S: Novo's Wegovy (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat2 outlets · 2026-10-01 11:11 UTC

Latest

  1. Dr. Praeger's, Novo Nordisk, Kings Food Markets cut New Jersey jobsnj1015.com · 2026-10-02 22:44 UTC · story
  2. Novo provides update on the denecimig Biologics License Application (BLA) in the US | Company Announcementinvestegate.co.uk · 2026-10-02 22:30 UTC · 1 more reports
  3. Novo Nordisk Says FDA Review of Hemophilia Drug Is Hitting Delaysmorningstar.com · 2026-10-02 22:28 UTC · story
  4. Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investorsfool.com · 2026-10-02 20:01 UTC · story
  5. With Zema out of breath, Novo is concerned about the possibility of being left without seats in the Alespveja.abril.com.br · 2026-10-02 18:30 UTC · story
  6. Novo Nordisk (NYSE: NVO) Wegovy Clears Liver Fat To Normal Levels In Nearly 9 Out Of 10 Obese Adults In STEP UP Trial Analysisforeignpolicyjournal.com · 2026-10-02 16:30 UTC · story
  7. Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?fool.com · 2026-10-02 16:15 UTC · story
  8. Participants Taking CagriSema Showed Changed Brain Responses to High-Calorie Food Images in Novo Study as FDA Decision Nearsmedicaldaily.com · 2026-10-02 13:30 UTC · story
  9. Novo lowers the price of Wegovy: Certain patients can save hundredsnyheder24.dk · 2026-10-02 12:45 UTC · 2 more reports
  10. Novo Nordisk: It's about much more than the weight-loss injectionfaz.net · 2026-10-02 12:40 UTC · story
  11. Novo reaches for a new obesity drug. It can be taken once a weekbankier.pl · 2026-10-02 04:44 UTC · story
  12. Novo will reach new target groups with Wegovy pillbt.dk · 2026-10-02 03:30 UTC · story
  13. Novo receives criticism for several illegal advertisements for weight loss medicationdr.dk · 2026-10-01 14:00 UTC · 1 more reports
  14. Novo Nordisk A/S: Novo's Wegovy (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fatfinanznachrichten.de · 2026-10-01 11:11 UTC · 1 more reports
  15. Novo lowers the price of the weight loss drug in Swedendagensps.se · 2026-10-01 05:03 UTC · story
  16. Novo cuts Wegovy price by 20% in Sweden as subsidy bid continuesswedenherald.com · 2026-10-01 04:00 UTC · story
  17. Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buyfool.com · 2026-09-30 23:10 UTC · story
  18. Novo Nordisk (NYSE: NVO) Ozempic 2 mg Linked To Lower Heart Attack And Stroke Risk Versus Switching To Mounjaro In Real-World Studyforeignpolicyjournal.com · 2026-09-30 17:35 UTC · story
  19. Novo’s investigational obesity and diabetes drug CagriSema reduces ‘food noise’ and shows benefits in organ and bone health – EASD 2026GlobeNewswire — public companies · 2026-09-30 12:30 UTC · 3 more reports
  20. Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?aol.com · 2026-09-30 14:44 UTC · story
  21. Ro and Novo Announce Research Collaboration to Generate First-of-its-Kind Real-World Evidence on the Wegovy® Pillprnewswire.com · 2026-09-30 10:08 UTC · story
  22. People switching from weight-loss injections to Novo's Wegovy® pill lost 4.1% body weight on average after three months, according to real-world data presented at EASD2026prnewswire.com · 2026-09-30 10:08 UTC · 1 more reports
  23. Novo Nordisk: After A 70+% Drop, It's A Great Investment (NYSE:NVO)seekingalpha.com · 2026-09-30 07:45 UTC · story
  24. Two people charged with selling counterfeit Novo drug in the USAbt.dk · 2026-09-30 00:55 UTC · story
  25. Obesity and diabetes drug dominance battle... Novo and Lilly argue figures to claim company superioritycdn.pharmnews.com · 2026-09-30 00:22 UTC · story
  26. Apostle, daily intake is troublesome?…Novo, 'once a week obesity drug' betcdn.medipana.com · 2026-09-29 22:58 UTC · story
  27. Nunes Marques determines Novo's participation in electoral debatesoantagonista.com · 2026-09-29 21:40 UTC · story
  28. Nunes Marques allows Zema and other Novo candidates to participate in debatesfolha.uol.com.br · 2026-09-29 21:31 UTC · story
  29. How much should Novo earn to avoid crisis?berlingske.dk · 2026-09-29 20:40 UTC · story
  30. Recon: FDA approves Egetis' Emcitate for rare genetic disease; Novo buys rights to Chinese weight-loss pill in $2.6B dealraps.org · 2026-09-29 19:05 UTC · story